Caladrius Biosciences Inc. (CLBS) declined -9.14% or -0.52 to $5.17. It is approximately 38462 shares traded, which is 85.94% compare to the average total volume 44756. The market cap of CLBS is $50.28 million. The year to date change is 44.64%. The 52 week price range is from $2.63 to $11.65. Price of CLBS have changed -3.56% during last week. It have changed 2.15% over last month, -7.78% over last 3 months, 6.55% over last 6 months and 58.50% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLBS is 5.39. It is 4.26% above current price. The 200-day Moving Averages for CLBS is 4.87. It is -5.80% below current price. The 52-week High is 11.65. It is 125.34% from the current price. The 52-week Low is 2.63. It is -49.13% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLBS is 1.66 on 2018-09-14. Short % to float is 2.62%. There are some statistics of CLBS. It is has market cap $50.28 million. The share outstanding is 9.73 million. The average volume is 44756. It has 59.45M cash and 359553 in debt. The percent of top 15 Institution holding is 6.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLBS is -31.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLBS is -24.51%.